Decreased alternative splicing of estrogen receptor-α mRNA in the Alzheimer's disease brain

Neurobiology of Aging

Volumn 33, Issue 2, 2012, Pages

  Ishunina, Tatjana A ^a,b   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Alzheimer's disease; Estrogen receptor ; Human brain; Splice variants

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MESSENGER RNA;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; LOCUS CERULEUS; MALE; NUCLEOTIDE SEQUENCE; OCCIPITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; TEMPORAL CORTEX; THALAMUS; WHITE MATTER;

EID: 82755179501     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.03.010     Document Type: Article

References (55)

1. Anandappa S.Y., Sibson R., Platt-Higgins A., Winstanley J.H.R., Rudland P.S., Barraclough R. Variant estrogen receptor α mRNAs in human breast cancer specimens. Int. J. Cancer 2000, 88:209-216.
2. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copelans J.R., Dartigues J.F., Kragh-Sorensen P., Baldereschi M., Brayne C., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999, 53:1992-1997.
3. Bollig A., Miksicek R.J. An estrogen receptor-α splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol 2000, 14:634-649.
4. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
5. Brandi M.L., Becherini L., Gennari L., Racchi M., Bianchetti A., Nacmias B., Sorbi S., Mecocci P., Senin U., Govoni S. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem. Biophys. Res. Commun 1999, 265:335-338.
6. Brinton R.D. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann. N. Y. Acad. Sci 2005, 1052:57-74.
7. Chaidarun S.S., Klibanski A., Alexander J.M. Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J. Clin. Endocrinol. Metab 1997, 82:1058-1065.
8. Conrad C., Zhu J., Conrad C., Schoenfeld D., Fang Z., Ingelsson M., Stamm S., Church G., Hyman B.T. Single molecule profiling of tau gene expression in Alzheimer's disease. J. Neurochem 2007, 103:1228-1236.
9. Corbo R.M., Gambina G., Ruggeri M., Scacchi R. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentration. Dement. Geriatr. Cogn. Disord 2006, 22:67-72.
10. Craig M.C., Murphy D.G.M. Alzheimer's disease in women. Best Pract. Res. Clin. Obstet. Gynaecol 2009, 23:53-61.
11. Daffada A.A., Dowsett M. Tissue-dependent expression of a novel splice variant of the human oestrogen receptor. J. Steroid Biochem. Mol. Biol 1995, 55:413-421.
12. Erenburg I., Schachter B., Mira y Lopez R., Ossowski L. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation. Mol. Endocrinol 1997, 11:2,004-2,015.
13. Ewing B., Hillier L.D., Wendl M.C., Green P. Base-calling of automated sequencer traces using phred. I. Accuracy Assessment. Genome Res 1998, 8:175-185.
14. Fasco M.J., Hurteau G.J., Spivack S.D. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol. Cell. Endocrinol 2002, 188:125-140.
15. Ferro P., Forlani A., Muselli M., Pfeffer U. Alternative splicing of the human estrogen receptor α primary transcript: mechanisms of exon skipping. Int. J. Mol. Med 2003, 12:355-363.
16. Fleige S., Pfaffl M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol. Aspects Med 2006, 27:126-139.
17. García-Pedrero J.M., Zuazua P., Martínez-Campa C., Lazo P.S., Ramos S. The naturally occurring variant of estrogen receptor (ER) ERδe7 suppresses estrogen-dependent transcriptional activation by both wild type ERα and ERβ. Endocrinology 2003, 144:2967-2976.
18. Garcia-Segura L.M., Balthazart J. Steroids and neuroprotection: new advances. Front. Neuroendocrinol. 2009, 30:v-ix.
19. Genazzani A.R., Pluchino N., Luisi S., Luisi M. Estrogen, cognition and female aging. Hum. Reprod. Update 2007, 13:175-187.
20. Glatz D.C., Rujescu D., Tang Y., Berendt F.J., Hartmann A.M., Faltraco F., Rosenberg C., Hulette C., Jellinger K., Hampel H., Riederer P., Möller H.J., Andreadis A., Henkel K., Stamm S. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J. Neurochem. 2006, 96:635-644.
21. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986, 231:1150-1154.
22. Heinzen E.L., Yoon W., Weale M.E., Sen A., Wood N.W., Burke J.R., Welsh-Bohmer K.A., Hulette C.M., Sisodiya S.M., Goldstein D.B. Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease. Genome Biol 2007, 8:R32.
23. Hogervorst E., Yaffe K., Richards M., Huppert F.A. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst. Rev 2009, 21. CD003799.
24. Hope A.D., de Silva R., Fischer D.F., Hol E.M., van Leeuwen F.W., Lees A.J. Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J. Neurochem 2003, 86:394-404.
25. Horvath G., Leser G., Helou K., Henriksson M. Function of the exon 7 deletion variant estrogen receptor α protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice. Gynecol. Oncol 2002, 84:271-279.
26. Hu C., Hyder S.M., Needleman D.S., Baker V.V. Expression of estrogen receptor variants in normal and neoplastic human uterus. Mol. Cell. Endocrinol 1996, 118:173-179.
27. Ishunina T.A., Fischer D.F., Swaab D.F. Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol. Aging 2007, 28:1670-1681.
28. Ishunina T.A., Swaab D.F., Bogolepova I.N. Estrogen receptor α in the hypothalamus and basal forebrain of Alzheimer's disease and vascular dementia cases. Morphological Newsletter 2007, 1-2:62-65.
29. Ishunina T.A., Swaab D.F., Fischer D.F. Estrogen receptor-alpha splice variants in the medial mamillary nucleus of Alzheimer's disease patients: identification of a novel MB1 isoform. J. Clin. Endocrinol. Metab 2005, 90:3757-3765.
30. Ishunina T.A., Swaab D.F. Age-dependent ERα MB1 splice variant expression in discrete areas of the human brain. Neurobiol. Aging 2008, 29:1177-1189.
31. Ishunina T.A., Swaab D.F. Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease. Neuroendocrinology 2009, 89:187-199.
32. Ji Y., Urakami K., Wada-Isoe K., Adachi Y., Nakashima K. Estrogen receptor gene polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia. Dement. Geriatr. Cogn. Disord 2000, 11:119-122.
33. Kassi E.N., Vlachoyiannopoulos P.G., Moutsopoulos H.M., Sekeris C.E., Moutsatsou P. Molecular analysis of estrogen receptor alpha and beta in lupus patients. Eur. J. Clin. Invest 2001, 31:86-93.
34. Kazama H., Ruberu N.N., Murayama S., Saito Y., Nakahara K., Kanemaru K., Nagura H., Arai T., Sawabe M., Yamanouchi H., Orimo H., Hosoi T. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles. Dement. Geriatr. Cogn. Disord 2004, 18:145-150.
35. Lambert J.C., Harris J.M., Mann D., Lemmon H., Coates J., Cumming A., St-Clair D., Lendon C. Are the estrogen receptors involved in Alzheimer's disease?. Neurosci. Lett. 2001, 306:193-197.
36. Leygue E., Huang A., Murphy L.C., Watson P.H. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res. 1996, 56:4324-4327.
37. Leygue E.R., Watson P.H., Murphy L.C. Estrogen receptor variants in normal human mammary tissue. J. Natl. Cancer Inst 1996, 88:284-290.
38. Maracchioni A., Totaro A., Angelini D.F., Di Penta A., Bernardi G., Carri M.T., Achsel T. Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration. J. Neurochem 2007, 100:142-153.
39. Mattila K.M., Axelman K., Rinne J.O., Blomberg M., Lehtimäki T., Laippala P., Röyttä M., Viitanen M., Wahlund L., Winblad B., Lannfelt L. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci. Lett. 2000, 282:45-48.
40. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
41. Murphy L.C., Wang M., Coutt A., Dotzlaw H. Novel mutations in the estrogen receptor messenger RNA in human breast cancers. J. Clin. Endocrinol. Metab 1996, 81:1420-1427.
42. Naftolin F., Malaspina D. Estrogen, estrogen treatment and the post-reproductive woman's brain. Maturitas 2007, 57:23-26.
43. Nagy E., Maquat L.E. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem. Sci 1998, 23:198-199.
44. Perlman W.R., Matsumoto M., Beltaifa S., Hyde T.M., Saunders R.C., Webster M.J., Rubinow D.R., Kleinman J.E., Weickert C.S. Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex. Neuroscience 2005, 134:81-95.
45. Ponglikitmongkol M., Green S., Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 1988, 7:3385-3388.
46. Poola I., Speirs V. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J. Steroid Biochem. Mol. Biol 2001, 78:459-469.
47. Porrello E., Monti M.C., Sinforiani E., Cairati M., Guaita A., Montomoli C., Govoni S., Racchi M. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur. J. Neurol 2006, 13:639-644.
48. Reisberg B., Ferris S.H., DeLeon M.J., Crook T. The Global Detelioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 1982, 139:1136-1139.
49. Rice L.W., Jazaeri A.A., Shupnik M.A. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma. Gynecol. Oncol 1997, 65:149-157.
50. Taylor S.E., Martin-Hirsch P.L., Martin F.L. Oestrogen receptor splice variants in the pathogenesis of disease. Cancer Lett. 2010, 288:133-148.
51. van Dijk M.A.J., Hart A.A.M., Van'T Veer L.J. Differences in estrogen receptor α variant messenger RNAs between normal human breast tissue and primary breast carcinomas. Cancer Res. 2000, 60:530-533.
52. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., Straub R.E., Weinberger D.R., Kleinman J.E. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum. Mol. Genet 2008, 17:2293-2309.
53. Wong J., Weickert C.S. Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia. J. Biol. Chem 2009, 284:18824-18832.
54. Yaffe K., Lui L.Y., Grady D., Stone K., Morin P. Estrogen receptor 1 polymorphism and risk of cognitive impairment in older women. Biol. Psychiatry 2002, 51:677-682.
55. Zhuang Y., Katzenellenbogen B.S., Shapiro D.J. Estrogen receptor mutants which do not bind 17 beta-estradiol dimerize and bind to the estrogen response element in vivo. Mol. Endocrinol 1995, 9:457-466.